Register today to learn about important impurities, and how new reference materials can streamline your Pharma QC workflow
Comprehensive assessment of a drug’s impurity profile is critical in assuring safe and effective products for patients and consumers. Whether you are assessing a known chromatographic impurity, or need to ensure compliance with the heavy metals listed in ICHQ3D, accurate and reliable analytical results are critical.
And your results are only as accurate as your reference standard.
In this webinar, we will discuss three important impurity groups: Elemental Impurities, Extractables & Leachables, and synthesis/degradation impurities. We will explore background on why these impurities are critical to accurately assess. In addition, the webinar will highlight developments in new Certified Reference Materials which help streamline the ability of Pharma QC labs to develop and implement robust analytical methods.
Register today and join us for an engaging discussion.
Presented by
Dr. Matthias Nold,
Global Product Manager
Dr Matthias Nold. has 12 years of experience in product management of reference materials. He has a phd in Organic Chemistry from the University of Basel in Switzerland and is currently product manager for Reference Materials at MilliporeSigma.
Michael Hurst,
Global Product Manager
Michael’s career has maintained a focus on Reference Materials and their application in streamlining analytical workflows across pharma, cannabis, clinical, and forensic toxicology industries. He has also held responsibilities in Sales Management, directing the North American Reference Materials Specialist organization. Currently a Product Manager in the Reference Materials organization of MilliporeSigma, Michael has core responsibilities managing Pharmaceutical Reference Materials.
